Cortexyme publishes data on P. gingivalis ability to infect neurons

by IOS PressP. gingivalisbacteria (arrows), after invading a neuron, causes damage to the cellular infrastructure and synapses. Credit: Cortexyme, Inc.Cortexyme, Inc., a clinical stage biop

Updated on: March 26,2024

Cortexyme publishes data on P. gingivalis ability to infect neurons

by IOS PressP. gingivalisbacteria (arrows), after invading a neuron, causes damage to the cellular infrastructure and synapses. Credit: Cortexyme, Inc.Cortexyme, Inc., a clinical stage biop

Updated on:March 26,2024

Research team identifies new treatment target for Alzheimer's disease

byLancaster UniversityAlzheimer's disease is the leading cause of dementia and disability in old age. Credit: Lancaster UniversityResearchers at the University of Leeds and Lancaster Univers

Updated on: March 28,2024

Research team identifies new treatment target for Alzheimer's disease

byLancaster UniversityAlzheimer's disease is the leading cause of dementia and disability in old age. Credit: Lancaster UniversityResearchers at the University of Leeds and Lancaster Univers

Updated on:March 28,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on: March 30,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on:March 30,2024

Testing memory over four weeks could predict Alzheimer's disease risk

by University of BristolCredit: CC0 Public DomainNew research suggests testing people's memory over four weeks could identify who is at higher risk of developing Alzheimer's disease befor

Updated on: May 05,2024

Testing memory over four weeks could predict Alzheimer's disease risk

by University of BristolCredit: CC0 Public DomainNew research suggests testing people's memory over four weeks could identify who is at higher risk of developing Alzheimer's disease befor

Updated on:May 05,2024

Three-minute test detects common form of dementia that's hard to diagnose

by Florida Atlantic UniversityJames E. Galvin, M.D., M.P.H., one of the most prominent neuroscientists in the country, and a professor in FAU's Charles E. Schmidt College of Medicine and Chri

Updated on: February 26,2024

Three-minute test detects common form of dementia that's hard to diagnose

by Florida Atlantic UniversityJames E. Galvin, M.D., M.P.H., one of the most prominent neuroscientists in the country, and a professor in FAU's Charles E. Schmidt College of Medicine and Chri

Updated on:February 26,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on: May 20,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on:May 20,2024

Alzheimer's trial screening data links high amyloid levels with early stage disease

by National Institutes of HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainThe first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer&#39

Updated on: April 20,2024

Alzheimer's trial screening data links high amyloid levels with early stage disease

by National Institutes of HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainThe first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer&#39

Updated on:April 20,2024

Brain's 'appetite control center' found to be different in people who are overweight or living with obesity

by University of CambridgeCredit: CC0 Public DomainCambridge scientists have shown that the hypothalamus, a key region of the brain involved in controlling appetite, is different in the brains of

Updated on: February 05,2024

Brain's 'appetite control center' found to be different in people who are overweight or living with obesity

by University of CambridgeCredit: CC0 Public DomainCambridge scientists have shown that the hypothalamus, a key region of the brain involved in controlling appetite, is different in the brains of

Updated on:February 05,2024

Computer simulations explore how Alzheimer's disease starts

by Rice UniversityA team of Rice University researchers built computer simulations of amyloid beta proteins to see what their energy landscapes reveal about the formation of plaques in patients w

Updated on: June 18,2024

Computer simulations explore how Alzheimer's disease starts

by Rice UniversityA team of Rice University researchers built computer simulations of amyloid beta proteins to see what their energy landscapes reveal about the formation of plaques in patients w

Updated on:June 18,2024

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa

Updated on: August 08,2024

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa

Updated on:August 08,2024

Hit the sleep 'sweet spot' to keep brain sharp

by Washington University School of MedicineCredit: CC0 Public DomainLike so many other good things in life, sleep is best in moderation. A multiyear study of older adults found that both short an

Updated on: May 13,2024

Hit the sleep 'sweet spot' to keep brain sharp

by Washington University School of MedicineCredit: CC0 Public DomainLike so many other good things in life, sleep is best in moderation. A multiyear study of older adults found that both short an

Updated on:May 13,2024